In an era where health and wellness take center stage, the quest for effective weight management solutions is paramount.

As of fiscal year-end 2024, Thermo Fisher carried roughly $31 billion in long- and short-term obligations. The PPD acquisition materially increased its leverage but the number has steadily come down.